LCN2 and cervical squamous intraepithelial neoplasia: However, this might open the possibility to design more prominent, multicentric, prospective studies to evaluate whether NGAL may be used as a prognosis biomarker in patients with CIN and, more specifically, in patients with AKI due to CIN.